These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
364 related articles for article (PubMed ID: 23140295)
1. Targeting CSC-related miRNAs for cancer therapy by natural agents. Bao B; Li Y; Ahmad A; Azmi AS; Bao G; Ali S; Banerjee S; Kong D; Sarkar FH Curr Drug Targets; 2012 Dec; 13(14):1858-68. PubMed ID: 23140295 [TBL] [Abstract][Full Text] [Related]
2. Targeting CSCs in tumor microenvironment: the potential role of ROS-associated miRNAs in tumor aggressiveness. Bao B; Azmi AS; Li Y; Ahmad A; Ali S; Banerjee S; Kong D; Sarkar FH Curr Stem Cell Res Ther; 2014 Jan; 9(1):22-35. PubMed ID: 23957937 [TBL] [Abstract][Full Text] [Related]
3. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Bao B; Azmi AS; Ali S; Ahmad A; Li Y; Banerjee S; Kong D; Sarkar FH Biochim Biophys Acta; 2012 Dec; 1826(2):272-96. PubMed ID: 22579961 [TBL] [Abstract][Full Text] [Related]
4. Embryonic stem cell microRNAs: defining factors in induced pluripotent (iPS) and cancer (CSC) stem cells? Gunaratne PH Curr Stem Cell Res Ther; 2009 Sep; 4(3):168-77. PubMed ID: 19492978 [TBL] [Abstract][Full Text] [Related]
5. Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells. Bao B; Ahmad A; Li Y; Azmi AS; Ali S; Banerjee S; Kong D; Sarkar FH Expert Opin Ther Targets; 2012 Oct; 16(10):1041-54. PubMed ID: 22877147 [TBL] [Abstract][Full Text] [Related]
6. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy. Bao B; Ahmad A; Azmi AS; Ali S; Sarkar FH Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.25. PubMed ID: 23744710 [TBL] [Abstract][Full Text] [Related]
7. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression. Sheng W; Chen Y; Gong Y; Dong T; Zhang B; Gao W Oncol Rep; 2016 Dec; 36(6):3387-3396. PubMed ID: 27779717 [TBL] [Abstract][Full Text] [Related]
8. Distinctive role of dysregulated miRNAs in chordoma cancer stem-like cell maintenance. Tuysuz EC; Gulluoglu S; Yaltirik CK; Ozbey U; Kuskucu A; Çoban EA; Sahin F; Türe U; Bayrak OF Exp Cell Res; 2019 Jul; 380(1):9-19. PubMed ID: 30951707 [TBL] [Abstract][Full Text] [Related]
9. Emerging role of microRNAs in cancer and cancer stem cells. Hao J; Zhao S; Zhang Y; Zhao Z; Ye R; Wen J; Li J J Cell Biochem; 2014 Apr; 115(4):605-10. PubMed ID: 24166873 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA regulation of cancer stem cells. Liu C; Tang DG Cancer Res; 2011 Sep; 71(18):5950-4. PubMed ID: 21917736 [TBL] [Abstract][Full Text] [Related]
11. microRNAs in cancer stem cells: Biology, pathways, and therapeutic opportunities. Asadzadeh Z; Mansoori B; Mohammadi A; Aghajani M; Haji-Asgarzadeh K; Safarzadeh E; Mokhtarzadeh A; Duijf PHG; Baradaran B J Cell Physiol; 2019 Jul; 234(7):10002-10017. PubMed ID: 30537109 [TBL] [Abstract][Full Text] [Related]
12. Cancer "stemness"- regulating microRNAs: role, mechanisms and therapeutic potential. Bhardwaj A; Arora S; Prajapati VK; Singh S; Singh AP Curr Drug Targets; 2013 Sep; 14(10):1175-84. PubMed ID: 23834145 [TBL] [Abstract][Full Text] [Related]
13. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. Ma Y; Shen N; Wicha MS; Luo M Cells; 2021 Sep; 10(9):. PubMed ID: 34572067 [TBL] [Abstract][Full Text] [Related]
14. Modulatory roles of microRNAs in the regulation of different signalling pathways in large bowel cancer stem cells. Mamoori A; Gopalan V; Smith RA; Lam AK Biol Cell; 2016 Mar; 108(3):51-64. PubMed ID: 26712035 [TBL] [Abstract][Full Text] [Related]
15. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Wang Z; Li Y; Ahmad A; Azmi AS; Kong D; Banerjee S; Sarkar FH Drug Resist Updat; 2010; 13(4-5):109-18. PubMed ID: 20692200 [TBL] [Abstract][Full Text] [Related]
16. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Brossa A; Fonsato V; Grange C; Tritta S; Tapparo M; Calvetti R; Cedrino M; Fallo S; Gontero P; Camussi G; Bussolati B Int J Cancer; 2020 Sep; 147(6):1694-1706. PubMed ID: 32064610 [TBL] [Abstract][Full Text] [Related]
17. Emerging roles for modulation of microRNA signatures in cancer chemoprevention. Neelakandan K; Babu P; Nair S Curr Cancer Drug Targets; 2012 Jul; 12(6):716-40. PubMed ID: 22515522 [TBL] [Abstract][Full Text] [Related]
18. MicroRNAs and cancer stem cells: the sword and the shield. Sun X; Jiao X; Pestell TG; Fan C; Qin S; Mirabelli E; Ren H; Pestell RG Oncogene; 2014 Oct; 33(42):4967-77. PubMed ID: 24240682 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics. Xia H; Hui KM Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591 [TBL] [Abstract][Full Text] [Related]
20. Stem cell programs in cancer initiation, progression, and therapy resistance. Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]